91 related articles for article (PubMed ID: 3607943)
1. Preparation and in vitro evaluation of sustained-release suppositories containing microencapsulated indomethacin.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Koishi M
Chem Pharm Bull (Tokyo); 1987 Mar; 35(3):1201-6. PubMed ID: 3607943
[No Abstract] [Full Text] [Related]
2. Preparation of sustained-release suppositories containing microencapsulated indomethacin and bioavailability of indomethacin in rabbits.
Nakajima T; Takashima Y; Iida K; Mitsuta H; Furuya A; Koishi M
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4249-54. PubMed ID: 3435949
[No Abstract] [Full Text] [Related]
3. Preparation of sustained-release suppositories of indomethacin using a solid dispersion system and evaluation of bioavailability in rabbits.
Ohnishi N; Yokoyama T; Umeda T; Kiyohara Y; Kuroda T; Kita Y; Kuroda K
Chem Pharm Bull (Tokyo); 1986 Jul; 34(7):2999-3004. PubMed ID: 3769103
[No Abstract] [Full Text] [Related]
4. Sustained release indomethacin: a double blind comparison with indomethacin suppositories.
Iversen O; Fowles M; Vlieg M; Smidt N; Wigley R
N Z Med J; 1981 Apr; 93(682):261-2. PubMed ID: 7019782
[TBL] [Abstract][Full Text] [Related]
5. Studies on sustained-release dosage forms. I. Preparation and bioavailability of indomethacin suppositories.
Umeda T; Matsuzawa A; Yokoyama T; Kuroda K; Kuroda T
Chem Pharm Bull (Tokyo); 1983 Aug; 31(8):2793-8. PubMed ID: 6652823
[No Abstract] [Full Text] [Related]
6. Indomethacin sustained-release suppositories containing sugar ester.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Apr; 38(4):1027-31. PubMed ID: 2379274
[TBL] [Abstract][Full Text] [Related]
7. Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro.
Kanke M; Tanabe E; Katayama H; Koda Y; Yoshitomi H
Biol Pharm Bull; 1995 Aug; 18(8):1154-8. PubMed ID: 8535416
[TBL] [Abstract][Full Text] [Related]
8. Study on absorption of indomethacin from sustained-release suppositories containing hydrogenated soybean lecithin in rabbits.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3145-7. PubMed ID: 2632063
[TBL] [Abstract][Full Text] [Related]
9. Indomethacin sustained-release suppositories containing sugar ester in polyethylene glycol base.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1990 Jun; 38(6):1680-3. PubMed ID: 2208382
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of indomethacin sustained-release suppositories using a hydroxypropylmethylcellulose acetate succinate-polyethylene glycol 2000 solid matrix.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Sep; 35(9):3935-9. PubMed ID: 3435990
[No Abstract] [Full Text] [Related]
11. Evaluation of indomethacin sustained-release suppositories prepared with a methacrylic acid-methacrylic acid methyl ester copolymer-polyethylene glycol 2000 solid matrix.
Ohnishi N; Yokoyama T; Kiyohara Y; Okumura K; Kuroda K
Chem Pharm Bull (Tokyo); 1988 Jan; 36(1):430-4. PubMed ID: 3378304
[No Abstract] [Full Text] [Related]
12. Study on slow-release of indomethacin from suppositories containing hydrogenated soybean lecithin.
Nakajima T; Takashima Y; Furuya A; Ozawa Y; Kawashima Y
Chem Pharm Bull (Tokyo); 1988 Sep; 36(9):3696-701. PubMed ID: 3240558
[No Abstract] [Full Text] [Related]
13. Studies on sustained-release dosage forms. II. Pharmacokinetics after rectal administration of indomethacin suppositories in rabbits.
Kuroda T; Yokoyama T; Umeda T; Matsuzawa A; Kuroda K; Asada S
Chem Pharm Bull (Tokyo); 1983 Sep; 31(9):3319-25. PubMed ID: 6667541
[No Abstract] [Full Text] [Related]
14. Effect of the molecular weight of polyethylene glycol on the bioavailability of indomethacin sustained-release suppositories prepared with solid dispersions.
Ohnishi N; Kiyohara Y; Kita Y; Kuroda K; Yokoyama T
Chem Pharm Bull (Tokyo); 1987 Aug; 35(8):3511-5. PubMed ID: 3427728
[No Abstract] [Full Text] [Related]
15. In vitro drug liberation and kinetics of sustained release indomethacin suppository.
Uzunkaya G; Bergişadi N
Farmaco; 2003 Jul; 58(7):509-12. PubMed ID: 12818689
[TBL] [Abstract][Full Text] [Related]
16. Studies of pharmacokinetics of indomethacin in man under consideration of bioavailability.
Hippius M; Reinicke C
Agents Actions Suppl; 1982; 10():109-17. PubMed ID: 6956211
[No Abstract] [Full Text] [Related]
17. Influence of storage temperature on indomethacin release from fatty-base suppositories in vitro and in vivo.
Yoshida T; Itoh Y; Gomita Y; Oishi R
Acta Med Okayama; 1991 Feb; 45(1):37-42. PubMed ID: 2063694
[TBL] [Abstract][Full Text] [Related]
18. [Clinical evaluation of sustained-release preparation of indomethacin].
Sasaki S
Ryumachi; 1972 Nov; 12(3):253-70. PubMed ID: 4576240
[No Abstract] [Full Text] [Related]
19. Development and evaluation of matrix and two layered sustained release suppositories of theophylline.
Maity S; Sa B; Bandyopadhyay AK
Boll Chim Farm; 2001; 140(6):462-6. PubMed ID: 11822240
[TBL] [Abstract][Full Text] [Related]
20. Preparation and evaluation of slow-release pan-coated indomethacin granules.
Eshra AG; Elkhodairy KA; Mortada SA; Nada AH
J Microencapsul; 1994; 11(3):271-8. PubMed ID: 8064551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
